PlainRecalls
FDA Devices Moderate Class II Terminated

Xpert MRSA Catalog GXMRSA-120, Rev. AJ Microbiology: The Cepheid Xpert MRSA assay performed in the GeneXpert Dx System (Xpert MRSA) is a qualitative in vitro diagnostic test designed for rapid detection of Methicillin-Resistant Staphylococcus Aureus (MRSA) from nasal swabs in patients at risk for nasal colonization

Reported: August 24, 2016 Initiated: July 18, 2016 #Z-2548-2016

Product Description

Xpert MRSA Catalog GXMRSA-120, Rev. AJ Microbiology: The Cepheid Xpert MRSA assay performed in the GeneXpert Dx System (Xpert MRSA) is a qualitative in vitro diagnostic test designed for rapid detection of Methicillin-Resistant Staphylococcus Aureus (MRSA) from nasal swabs in patients at risk for nasal colonization

Reason for Recall

Internal investigation found the certain lots of MRSA kits have the potential for performance issues at lower positive sample concentrations.

Details

Recalling Firm
Cepheid
Units Affected
68 kit for lot 1000037539 and 127 kit s for lot 1000029307.
Distribution
US only: PA, DE, FL, SC, ME, CA, IL, NC, TX, WA, NY, TN, FL, OR, OK, MO, MS, GA, NM, IN, OH, MD, VA, CO, AZ, and NC.
Location
Sunnyvale, CA

Frequently Asked Questions

What product was recalled?
Xpert MRSA Catalog GXMRSA-120, Rev. AJ Microbiology: The Cepheid Xpert MRSA assay performed in the GeneXpert Dx System (Xpert MRSA) is a qualitative in vitro diagnostic test designed for rapid detection of Methicillin-Resistant Staphylococcus Aureus (MRSA) from nasal swabs in patients at risk for nasal colonization. Recalled by Cepheid. Units affected: 68 kit for lot 1000037539 and 127 kit s for lot 1000029307..
Why was this product recalled?
Internal investigation found the certain lots of MRSA kits have the potential for performance issues at lower positive sample concentrations.
Which agency issued this recall?
This recall was issued by the FDA Devices on August 24, 2016. Severity: Moderate. Recall number: Z-2548-2016.